Published in Hepatitis Weekly, December 16th, 2002
A.S.F. Lok and colleagues, Innogenet NV, Ghent, Belgium, compared sequencing data with results from the company's INNO-LiPA HBV DR line probe assay (LiPA). This assay is based on reverse hybridization of amplified HBV DNA fragments with specific nucleotide probes immobilized on nitrocellulose strips.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly